Figure 2
From: Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
Kaplan-Meier estimates of overall survival in AIS patients. (A) 76 AIS patients, (B) 17 AIS patients with E2A-PBX1 fusion transcripts, (C) 59 AIS patients without E2A-PBX1 fusion transcripts, (D) 51 AIS patients at stage I, (E) 24 AIS patients at stage IA, and (F) 17 AIS female patients at stage IA. The patients were grouped by either gender (in panels A, B and C) or the status of E2A-PBX1 fusion transcripts (in panels D, E, and F).